Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes? - Zhao, Li-Min; Zhang, Miao; Zhan, Ze-Lin; Qiu, Mei (Frontiers in Cardiovascular Medicine, 2021)